Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers - PubMed (original) (raw)
Review
Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers
E Reed Smith et al. J Emerg Med. 2005 May.
Abstract
Ingestion of 1-2 tablets of chloroquine or hydroxylchloroquine is thought to predispose children under 6 years of age to serious morbidity and mortality. The actual risk to the toddler and appropriate guidelines for care remain unclear at a time when both medications are therapeutically utilized as anti-inflammatory agents in addition to their main use as anti-parasitics. A review of the literature and data from the American Association of Poison Control Centers reveals instances where exposure to as little as 1-2 tablets of chloroquine resulted in serious consequences. Based on these findings, ingestions of greater than 10 mg/kg of chloroquine base or unknown amounts require triage to the nearest health care facility for 4-6 h of observation. There is very limited data on pediatric hydroxychloroquine overdoses and no reports of toxicity from 1-2 pills, but given its similarity to chloroquine, it also should be considered potentially toxic at small doses. Thus, similar recommendations should be followed for triage after accidental hydroxychloroquine overdose.
Similar articles
- Are one or two dangerous? Phenothiazine exposure in toddlers.
Love JN, Smith JA, Simmons R. Love JN, et al. J Emerg Med. 2006 Jul;31(1):53-9. doi: 10.1016/j.jemermed.2005.08.013. J Emerg Med. 2006. PMID: 16798156 Review. - Are one or two dangerous? Quinine and quinidine exposure in toddlers.
Huston M, Levinson M. Huston M, et al. J Emerg Med. 2006 Nov;31(4):395-401. doi: 10.1016/j.jemermed.2006.07.018. J Emerg Med. 2006. PMID: 17046481 Review. - Are one or two dangerous? Calcium channel blocker exposure in toddlers.
Ranniger C, Roche C. Ranniger C, et al. J Emerg Med. 2007 Aug;33(2):145-54. doi: 10.1016/j.jemermed.2007.02.010. Epub 2007 Jul 5. J Emerg Med. 2007. PMID: 17692766 Review. - Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, Wax PM, Manoguerra AS, Scharman EJ, Olson KR, Chyka PA, Christianson G, Troutman WG. Woolf AD, et al. Clin Toxicol (Phila). 2007;45(3):203-33. doi: 10.1080/15563650701226192. Clin Toxicol (Phila). 2007. PMID: 17453872 - Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management.
Cobaugh DJ, Erdman AR, Booze LL, Scharman EJ, Christianson G, Manoguerra AS, Caravati EM, Chyka PA, Woolf AD, Nelson LS, Troutman WG. Cobaugh DJ, et al. Clin Toxicol (Phila). 2007 Dec;45(8):918-42. doi: 10.1080/15563650701665142. Clin Toxicol (Phila). 2007. PMID: 18163235
Cited by
- Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis.
Wang Q, Zhou J, Zhang B, Tian Z, Tang J, Zheng Y, Huang Z, Tian Y, Jia Z, Tang Y, van Velkinburgh JC, Mao Q, Bian X, Ping Y, Ni B, Wu Y. Wang Q, et al. PLoS Pathog. 2013;9(6):e1003410. doi: 10.1371/journal.ppat.1003410. Epub 2013 Jun 27. PLoS Pathog. 2013. PMID: 23825942 Free PMC article. Clinical Trial. - Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
Ursing J, Kofoed PE, Rodrigues A, Blessborn D, Thoft-Nielsen R, Björkman A, Rombo L. Ursing J, et al. J Infect Dis. 2011 Jan 1;203(1):109-16. doi: 10.1093/infdis/jiq001. J Infect Dis. 2011. PMID: 21148503 Free PMC article. Clinical Trial. - The utilization of hydroxychloroquine to reduce the main signs and symptoms of COVID-19 patients, a cross-sectional study.
Alsuwaidan S, Memish ZA, Alaklobi F, Khan K, Alajami HN. Alsuwaidan S, et al. Ann Med Surg (Lond). 2021 Oct;70:102867. doi: 10.1016/j.amsu.2021.102867. Epub 2021 Sep 16. Ann Med Surg (Lond). 2021. PMID: 34545307 Free PMC article. - Controversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases.
Solano JJ, Mendelsohn RA, Ahmed RA, Shih RD, Clayton LM, Alter SM, Hughes PG. Solano JJ, et al. Cureus. 2022 Jun 21;14(6):e26176. doi: 10.7759/cureus.26176. eCollection 2022 Jun. Cureus. 2022. PMID: 35891806 Free PMC article. - Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations.
Karalis V, Ismailos G, Karatza E. Karalis V, et al. Saf Sci. 2020 Sep;129:104842. doi: 10.1016/j.ssci.2020.104842. Epub 2020 May 21. Saf Sci. 2020. PMID: 32501367 Free PMC article.